All treatments
Treatment
URSODEOXYCHOLIC ACID clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
Efficacy and safety of Ursodeoxycholic Acid as a new therapy for the treatment of hepatorenal polycystic diseases, genetic study and determination of prognostic biomarkers.
This study is testing a medication called Ursodeoxycholic Acid for polycystic diseases affecting the liver and kidneys. Researchers want to see if it can shrink cysts and improve health. It's an early-stage study, focusing on safety and how well the treatment works in a small group of people.
For: Hepatorenal polycystic diseasesSpain - Active not recruitingPHASE4
Ursodeoxycholic Acid vs Metformin in Gestational Diabetes Mellitus
This study compares two medicines, Ursodeoxycholic Acid and Metformin, for treating diabetes that starts during pregnancy (gestational diabetes). We want to see which one works better at controlling blood sugar in women who are overweight or obese and need medicine for their diabetes.
For: Gestational DiabetesUnited Kingdom